Propofol

Polyp

Mount Carmel Health SystemSmall moleculePhase 4 / ApprovedDormant

BB

69/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 54/ 100
Competitive Position: 95/ 100

Competitive context

0 Active assets in the Polyp cohort.

Asset / Sponsor	Phase	Rating
Fentanyl Mount Carmel Health System	Phase 4	BB
Midazolam Mount Carmel Health System	Phase 4	BB
Aspirin Dartmouth-Hitchcock Medical Center	Phase 2/3	B
Marble Dust Dartmouth-Hitchcock Medical Center	Phase 2/3	B
Folate Dartmouth-Hitchcock Medical Center	Phase 2/3	B

Same molecule, other indications

Propofol is also rated in:

headache disorderDormant

BBB

Indicative · Phase 4

73 / 100

morbid obesityActive

BBB

Indicative · Phase 4

73 / 100

Alzheimer diseaseActive

BBB

Indicative · Phase 4

73 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.